260 related articles for article (PubMed ID: 33904775)
21. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
22. A feasibility study of microwave ablation for papillary thyroid cancer close to the thyroid capsule.
Wu J; Zhao ZL; Cao XJ; Wei Y; Peng LL; Li Y; Yu MA
Int J Hyperthermia; 2021; 38(1):1217-1224. PubMed ID: 34384314
[TBL] [Abstract][Full Text] [Related]
23. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study.
Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J
Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786
[TBL] [Abstract][Full Text] [Related]
24. Pathology confirmation of the efficacy and safety of microwave ablation in papillary thyroid carcinoma.
Ding M; Wu GS; Gu JH; Shen DJ; Zhou R; Liu Y; Xie RL; Wang SR; Wang HC; Fei J
Front Endocrinol (Lausanne); 2022; 13():929651. PubMed ID: 35983517
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis.
Tang W; Tang X; Jiang D; Zhang X; Wang R; Niu X; Zang Y; Zhang M; Wang X; Zhao C
Front Endocrinol (Lausanne); 2022; 13():967044. PubMed ID: 36072932
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Yu MA
J Clin Endocrinol Metab; 2021 Aug; 106(9):2707-2717. PubMed ID: 33846740
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study.
Xiao J; Zhang M; Zhang Y; Yan L; Lan Y; Zhu Y; Zhang Y; Lin L; Tang J; Luo Y
Int J Hyperthermia; 2020; 37(1):392-398. PubMed ID: 32340500
[No Abstract] [Full Text] [Related]
28. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
29. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study.
Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J
Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety, and controversy of ultrasound-guided radiofrequency ablation in the treatment of T1N0M0 papillary thyroid carcinoma.
Yi Z; Siyu L; Lijun F; Danhua Z; Jianhua L; Xinguang Q
Front Oncol; 2022; 12():1068210. PubMed ID: 36605434
[TBL] [Abstract][Full Text] [Related]
32. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the safety and efficacy of microwave ablation in treatment of cervical metastatic lymph nodes of papillary thyroid carcinoma compared to repeat surgery.
Tang W; Sun W; Niu X; Wang X; Wang X; Zhang M; Wang R; Jiang W; Jiang D; Zhao C
Int J Hyperthermia; 2022; 39(1):813-821. PubMed ID: 35719117
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Thermal Ablation Techniques for the Treatment of Primary Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis.
Choi Y; Jung SL
Thyroid; 2020 May; 30(5):720-731. PubMed ID: 31801432
[No Abstract] [Full Text] [Related]
35. Rigorous radiofrequency ablation can completely treat low-risk small papillary thyroid carcinoma without affecting subsequent surgical management.
Li X; Li J; Qiao Z; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Eur Radiol; 2023 Jun; 33(6):4189-4197. PubMed ID: 36538070
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
Guo J; Arellano RS
AJR Am J Roentgenol; 2021 Jan; 216(1):117-124. PubMed ID: 32603227
[No Abstract] [Full Text] [Related]
37. Microwave Ablation for Papillary Thyroid Microcarcinoma with and without US-detected Capsule Invasion: A Multicenter Prospective Cohort Study.
Zheng L; Dou JP; Han ZY; Liu FY; Yu J; Cheng ZG; Yu XL; Wang H; Cong ZB; Wang SR; Yu MA; Xu ZF; Che Y; Nan B; Liu C; Hao Y; Wang X; Liu Y; Zhou Y; Liang P
Radiology; 2023 May; 307(3):e220661. PubMed ID: 36880949
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study.
Han ZY; Dou JP; Zheng L; Che Y; Yu MA; Wang SR; Wang H; Cong ZB; He JF; Qian TG; Hu QH; He GZ; Liu G; Yu SY; Guo JQ; Jiang TA; Feng RF; Li QY; Chen XJ; Zhu YL; Wei Y; Liu LH; Wang X; Qi LN; Liang P
Eur Radiol; 2023 Nov; 33(11):7942-7951. PubMed ID: 37294329
[TBL] [Abstract][Full Text] [Related]
40. Over than three-year follow-up results of thermal ablation for papillary thyroid carcinoma: A systematic review and meta-analysis.
Xue J; Teng D; Wang H
Front Endocrinol (Lausanne); 2022; 13():971038. PubMed ID: 36353232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
